Kedrion
Kedrion Biopharma, commonly referred to as Kedrion, is a leading global player in the biopharmaceutical industry, headquartered in Italy. Founded in 2001, the company has established a strong presence in major operational regions, including Europe and North America, focusing on the development and production of human plasma-derived therapies. Kedrion's core offerings include immunoglobulins, clotting factors, and albumin, which are essential for treating various medical conditions. What sets Kedrion apart is its commitment to quality and innovation, ensuring that its products meet the highest safety standards. With a robust market position, Kedrion has achieved significant milestones, including expanding its product portfolio and enhancing its global distribution network, solidifying its reputation as a trusted provider in the biopharmaceutical sector.
DitchCarbon Score
How does Kedrion's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Kedrion's score of 31 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Kedrion's reported carbon emissions
In 2023, Kedrion reported total carbon emissions of approximately 60,821 kg CO2e, comprising about 27,304 kg CO2e from Scope 1 emissions and about 33,517 kg CO2e from Scope 2 emissions. This marks a notable decrease from previous years, particularly from 2022, where emissions were approximately 66,104 kg CO2e, with Scope 1 emissions at about 30,122 kg CO2e and Scope 2 emissions at about 35,982 kg CO2e. Kedrion's emissions data from 2016 to 2023 shows a fluctuating trend, with significant emissions recorded in earlier years, such as 46,373,000 kg CO2e in 2017 and 32,736,000 kg CO2e in 2020. The company has not disclosed any Scope 3 emissions data, which typically includes indirect emissions from the supply chain and product use. Despite the absence of specific reduction targets or commitments to the Science Based Targets initiative (SBTi), Kedrion's ongoing efforts to monitor and report emissions reflect a commitment to transparency and accountability in their climate impact. The company continues to focus on reducing its carbon footprint as part of its broader sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Scope 1 | 32,365,000 | 00,000,000 | 00,000,000 | 0,000 | 00,000,000 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 18,358,000 | 00,000,000 | 00,000,000 | 00 | 00 | 00,000 | 00,000 | 00,000 |
| Scope 3 | - | - | - | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kedrion is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
